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ABSTRACT 
 
Functional gastrointestinal disorders (FGDs) have been related with different psychological 
conditions. On the contrary the role of psychological factors within gastrointestinal motor disorders 
(GMDs) remains unclear. The objective of this study was to explore the differences and congruence 
with clinical performance of the psychological profile and subjective functionality among patients 
diagnosed with FGDs and GMDs. Using a double-blind design, fifty-six inpatients from a 
Gastroenterology Department were included in the study. No major differences were detected 
between the two groups. However, clinical performance was coherent with subjective physical 
functioning only among GMDs. These results may provide useful information for gastroenterologists 
dealing with patients’ complaints not consistent with their clinical profile. 
 
Keywords: Functional gastrointestinal disorders, gastrointestinal motility disorders, clinical 
performance, subjective functionality, congruence. 
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INTRODUCTION 
Some patients complain of severe digestive symptoms in the absence of organic causes. Symptoms 
include abdominal discomfort and/or pain, abdominal distension and inability to consume regular 
meals. From a gastroenterological point of view, two main diagnostic categories are distinguished: 
patients in whom a motor dysfunction of the gut can be evidenced by objective criteria (i.e. abnormal 
motility) classified as gastrointestinal motor disorder (GMDs) and those without objective 
dysfunction. The clinical manifestations in both categories may be indistinguishable, and the 
distinction in the most severe cases requires functional tests such as intestinal manometry. Patients 
without demonstrable GMDs are diagnosed with functional gastrointestinal disorders, (FGDs, 
Drossman, 2006). Different functional gastrointestinal syndromes have been defined based on clinical 
criteria. They include irritable bowel syndrome (abdominal pain or discomfort associated with 
changes in bowel habit), functional dyspepsia (symptoms thought to be originated in the gastro-
duodenal region in the absence of any organic, systemic, or metabolic disease likely to explain the 
symptoms) and rumination (persistent or recurrent regurgitation of recently-ingested food into the 
mouth with subsequent spitting or re-mastication and swallowing, in the absence of structural 
disease). The causes of functional gastrointestinal disorders are still unknown, hence functional stands 
actually for idiopathic. Experimental data suggest that FGD symptoms are related to subtle sensory 
and reflex dysfunctions of the gut that are not detectable by conventional methodologies, leading to 
reduced tolerance of physiological stimuli in the gut. 
 
Moreover, there is evidence that the development of symptoms is the result of interactions between 
somatic, psychological, and social factors with high interpersonal variability (Bennett et al., 1998). 
They are often associated with psychological distress (Koloski, Talley, & Boyce, 2003), personality 
characteristics (Fava, Fabbri, Sirri, & Wise, 2007), child abuse (Lackner et al., 2006), and 
sociocultural issues mainly related to lifestyles, gender and explanatory models of the disorder among 
patients and physicians (Chang et al., 2006). Furthermore, epidemiological data points to the presence 
of psychiatric comorbidities in 40-60% of patients diagnosed with FGDs (Levy et al., 2006). It has 
been suggested that people suffering FGDs but not seeking medical advice, have a similar 
psychological profile to asymptomatic individuals (Drossman et al., 1999). On the contrary, patients 
with a FGD demanding medical specialised care have more anxiety, depression, health-related 
anxiety and hypochondriac symptoms; and are less likely to link distress with their symptoms, 
compared to people not consulting or remaining in primary care (Guthrie et al., 2003; Heaton et al., 
1992; Whitehead, Bosmajian, Zonderman, Costa  Jr., & Schuster, 1988). Likewise, some recent 
studies show similar results in community and primary care settings, suggesting a direct relationship 
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between psychological co-morbidity and FGDs, rather than a biased observations in referral centres 
(Wu, 2012). 
 
While FGDs have been widely studied from a psychological perspective, often showing the presence 
of diverse symptomatology (Bennett et al., 1998; Drossman et al., 1999; Heaton et al., 1992; 
Whitehead et al., 1988; Wu, 2012), GMDs have received less attention from the behavioural sciences. 
This can be explained as these disorders are evidenced by a structural disease to justify it. However, 
some  studies point out to psychiatric illness causing gastric dysmotility (Peupelmann et al., 2009; 
Quick et al., 2010; Ruhland et al., 2008). In addition, anxiety and depression levels have been 
associated with gastroparesis severity and hospitalizations but not with disease aetiology or degree of 
gastric retention in a wide sample of gastroparesis patients (Hasler et al., 2010). 
 
However, despite all this evidence, the differences between GMDs and FGDs have not still been 
explored in the context of specialized tertiary care, where the most severe cases are typically treated.. 
For all these reasons, the aim of this study was to compare the psychological, subjective functionality 
and clinical assessed performance profiles of patients admitted for specialised assessment in an 
inpatient tertiary Digestive Unit. 
 
METHODS 
Participants 
During one year, all patients hospitalized for evaluation of gastrointestinal motor function in a highly 
specialized Digestive Unit based at a tertiary referral centre, were included in this study. Patients had 
been referred because of suspected gastrointestinal motor abnormality and organic lesions. 
Mechanical obstruction had been ruled out by a thorough work-up before inclusion in the study. The 
protocol of the study was approved by the Ethics Committee of the University Hospital Vall d’Hebron 
and all participants gave their written informed consent. 
 
Clinical assessment 
All patients underwent gastrointestinal and psychiatric evaluation. Among patients not fulfilling 
criteria of intestinal dysmotility, those with clinical symptoms compatible with gastroparesis, 
underwent gastric emptying and gastric tone evaluation. Patients without objective evidence of motor 
disorder (inability, pseudo-obstruction, or gastroparesis) were evaluated using Rome III criteria to 
establish a FGD diagnosis. 
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Regarding psychiatric and psychological assessment, a clinical interview and a battery of 
psychometric tests were administered in the first 72 hours after hospital admission. All the semi-
structured interviews were carried out by the same psychiatrist (who was completely blind to patients’ 
digestive diagnosis or any previous clinical information), covering main psychopathological domains 
according to the SCID I (First, Spitzer, Gibbon, & Williams, 1997) & II (First, Gibbon, & Spitzer, 
1997) based on the DSM-IV-TR (American Psychiatric Association, 2000). The selection of 
questionnaires was done according to the basic psychometric evaluation protocol of the hospital’s 
liaison psychiatry service, including perceived functionality, depression and anxiety, general 
psychopathology, and personality traits. Additionally, the assessment of alexithymia was introduced, 
given the findings in studies reporting the increased presence of this trait in patients diagnosed with 
FGDs (Mazaheri, Afshar, Weinland, Mohammadi, & Adibi, 2012; Porcelli et al., 2004; Porcelli, De 
Carne, & Leandro, 2014). The battery of self-administered questionnaires included: 
 
a) Self-perceived functionality: The Short Form Health Survey, SF-36 (Ware Jr. & Sherbourne 
Donald, 1992) was used to measure subjective physical and social functionality. 
 
b) Psychopathology: The Toronto Alexithymia Scale, TAS-20 (Martínez-Sánchez, 1996; Taylor 
et al., 1988), was used to assess alexithymia, defined as an inability to identify and describe emotions 
in the self,  (Sifneos, 1973), the Hospital Anxiety and Depression Scale, HAD (Zigmond & Snaith, 
1983) to assess anxiety and depression; the Symptom Checklist Revised, SCL-90R (Derogatis, 1994) 
as a multidimensional measure of general psychopathology (including somatization, obsessive-
compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation 
and psychoticism domains). 
 
c) Personality traits: The Revised Neuroticism-Extroversion-Openness Five Factor Inventory, 
NEO-FFI (McCrae & Costa Jr., 2004) was used for the assessment of personality traits including 
extraversion, agreeableness, conscientiousness, neuroticism, and openness to experience. 
 
d) Physical assessment: Clinical functional impairment was assessed with the Karnofsky Performance 
Status (KPS, Karnofsky and Burchenal, 1949). This clinician-administered scale covers a range from 
0 (death) to 100 (perfect health). Although it was initially designed to be used with patients diagnosed 
with cancer, its use has been extended to other medical conditions including digestive disorders 
(Borgaonkar, 2000). 
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Statistical analyses 
Non parametric statistics were used to compare socio-demographic characteristics and psychological 
measures between groups. Categorical variables were compared between groups using chi-square 
tests. Continuous variables were compared using Mann–Whitney–Wilcoxon rank-sum test for 
independent variables with two levels, and Kruskal-Wallis H for independent variables with 3 levels. 
Spearman’s Rho, a non-parametric statistic, was used to correlate clinical performance with 
subjective functioning, psychopathology, and personality traits. In the case of multiple comparisons, 
Bonferroni adjustment was used to correct the alpha level. 
 
RESULTS 
During the study period, fifty-six patients were enrolled in the study (see Figure 1). Four patients 
were excluded from the study after psychiatric and digestive assessment, as they did not meet criteria 
for neither FGD nor a GMD (two met criteria for anorexia nervosa, one for a cluster C personality 
disorder and the last one did not fulfil any psychiatric or digestive diagnosis). Based on 
gastrointestinal function tests (intestinal manometry and gastric emptying) patients were classified in 
two subgroups: 17 patients were diagnosed with GMDs (7 inability, 2 gastroparesis and 8 chronic 
intestinal pseudo-obstruction), and the rest (35 patients in which no objective evidence was found) 
were diagnosed with FGDs (10 functional dyspepsia, 18 IBS, 7 rumination). 
 
PLEASE INSERT FIGURE 1 AROUND HERE 
 
Sociodemographic and psychosocial characteristics 
Sociodemographic and psychosocial characteristics are shown in table 1. Patients with objective 
criteria of gastrointestinal motor dysfunction were younger than those without (i.e. patients diagnosed 
of functional gastrointestinal disorders), although no statistical significant differences were found. 
Differences were neither found in the distribution of gender, education, professional activity, marital 
status or family dynamics. 
 
PLEASE INSERT TABLE 1 AROUND HERE 
 
Psychometric scales 
Psychometric variables are shown in table 2. Patients with motor disorders (GMDs) performed better 
(higher scores) in SF-36-Physical Role (z=2.186, p=.029), but not in other SF-36 subscales. No 
statistically significant differences were found in depression (HAD), anxiety (HAD), alexithymia 
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(TAS-20), general psychopathology (SCL-90), personality traits (NEO-FFI-R) or clinical severity 
(KPS). 
 
Regarding sub-diagnoses, no statistically significant differences were found between GMD 
subgroups (we compared a group of inability or gastroparesis with chronic intestinal pseudo-
obstruction using Mann-Whitney U) regarding any psychometric measure. On the contrary, among 
patients diagnosed of FGDs (we compared functional dyspepsia, IBS and 7 rumination using Kruskal-
Wallis H), those with rumination had higher scores in the SF-36 Physical Functioning (χ2=7.474, 
p=.024), NEO-FFI-R Agreeableness (χ2=5.843, p=.050) and Conscientiousness (χ2=6.40, p=.044) 
scores, compared to patients diagnosed with functional dyspepsia and IBS. No difference remained 
statistically significant after Bonferroni adjustment (0.05/26=0.002). 
 
PLEASE INSERT TABLE 2 AROUND HERE 
 
Correlation between clinician assessed performance and subjective functionality 
The correlation between clinician (KPS) and patient’s assessments of functionality (SF-36 subscales) 
and the rest of the psychometric measures in both groups, showed statistical significant correlations 
for SF-36 Physical Functioning (ρ=.378, p=.010), NEO-FFI Extraversion (ρ=.313, p=.034) and NEO-
FFI Conscientiousness (ρ=.323, p=.028). Partial correlations controlling for diagnosis showed 
statistical significant correlations for SF-36 Physical Functioning (r=.438, p=.003). When stratifying 
the analysis, patients with GMDs had statistically significant correlations with SF-36 physical 
functioning (ρ=.752, p=.002) and SF-36 physical role (ρ=.540, p=.046), while FGDs didn’t reach 
statistical significance for any correlation. For a graphical representation of the correlation of the KPS 
with SF-36 physical functioning, including 95% confidence intervals, please see figure 2. 
 
PLEASE INSERT FIGURE 2 AROUND HERE 
 
DISCUSSION 
Our results show that, among patients with severe symptoms assessed in tertiary care, those diagnosed 
with FGDs have a similar psychological profile and illness severity to those diagnosed with GMDs. 
However, despite this similarity, clinician-rated severity was not consistent with the subjective 
perception of functionality, in the case of patients diagnosed with FGDs. 
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This is the first study comparing different psychological and psychopathological variables between 
GMDs and FGDs in a detailed way. Additionally, psychometric and psychiatric assessment was done 
blind to digestive diagnosis. Our results focused on the relation between clinician-rated performance, 
patient-perceived functionality and other psychometric measures including alexithymia, depression, 
anxiety, general psychopathology, and personality traits. On the one hand, differences between FGDs 
and GMDs were only found for the SF-36-Physical Role subscale. On the other hand, clinician-rated 
severity correlated with subjective functionality just in the case of patients diagnosed with GMDs, 
showing a lack of coherence between clinician-rated severity and perceived functionality for FGD-
diagnosed patients. 
 
The scores in psychometric measures, even among patient-rated functionality scores (SF-36), were 
similar in both groups. This similarity may be explained in the context of a tertiary referral centre, 
where patients diagnosed with GMDs and FGDs have an equivalent clinician-rated severity. It should 
be kept in mind that patients diagnosed with FGDs included in this study have a more severe clinical 
picture that those usually found in the general population or in primary care (Koloski et al., 2003; 
Okumura, Tanno, Ohhira, & Tanno, 2010). Although patients with FGDs have been found to have 
higher levels of neuroticism, distress and anxiety compared with the general population in previous 
studies, these traits have not been found to differentiate patients consulting with those who do not 
(Koloski, Talley, & Boyce, 2002). 
 
Incongruence of self-reported vs. clinician-reported measures of functionality or severity can be 
seldom found in the medical literature (Cowen, Wakefield, & Cloutier, 2007; Elser & Fantl, 1995; 
Schrader, 1997), but are rarely explored more in depth. To our knowledge, it is the first time this topic 
is analysed among patients with gastrointestinal pathologies. On the one hand, patients diagnosed 
with GMD would seem “coherent” with what is expected of them. Patients with more severe clinical 
pictures, including eating limitations or nasogastric tubes, would have consistent physical functioning 
problems. On the other hand, some patients diagnosed with FGDs report levels of functionality 
inconsistent with what clinicians would expect from them. We may approach these results in two 
ways. Firstly we may appeal to the supposed objectivity of clinical judgment. From this point of view 
these patients would be perceiving levels of functionality below what they are "really" capable of. 
However, this may also have to do with a clash of clinician’s and patient’s expectations. Clinicians’ 
may find clinical complaints to be not consistent with their exploration, while patients might attribute 
these symptoms to the gastric disease. This leads us to believe that more studies in the future should 
study in depth factors causing inconsistencies between self- and hetero-reported clinical data. 
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Several limitations of the study should also be noted. On one hand, given the low prevalence of 
GMDs, the sample was too small to deepen in the determinants of the incongruence between 
subjective and clinician-assessed functionality. On the other hand, these patients have very severe 
conditions. For this reason, they are derived to a highly specialized unit in a tertiary referral centre. 
Hence, our data cannot be generalized to primary care patients or the general population. 
 
Despite these limitations, the results of this study may allow the medical community to think about 
future projects that could further investigate the determinants of the congruence between clinician-
reported measures and self-perceived functionality in patients diagnosed with digestive disorders. 
With respect to this line of research, more studies will be needed to check for different profiles within 
both diagnostic groups that could explain the inconsistency of subjective with clinician-assessed 
functionality. 
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Figure 1. Flow diagram of the study. 
 
Assessed for eligibility (n=56) 
Excluded, no FGD or GMD (n=4) 
   Anorexia nervosa (n=2) 
   Cluster C personality disorder (n=1) 
   No psychiatric disorder (n=1) 
Functional gastrointestinal disorders (n=35) 
 Irritable Bowel Syndrome (n=18) 
 Functional Dyspepsia (n=10) 
 Rumination (n=7) 
Gastrointestinal motor disorders (n=17) 
 Inability (n=7) 
 Gastroparesia (n=2) 
 Pseudo-obstruction (n=8) 
Included (n=52) 
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Table 1. Sociodemographic and psychosocial characteristics of the sample 
 FGD (n=28) GMD (n=17) Significance between FGD and GMD 
 M SD M SD  
 
Age (M±SD) 41.94 ±14.28 35.76 ±14.83 (z=-1.747, p=.081) 
      
 N % N %  
 
Sex (% females) 
 
30 
 
85.7 
 
13 
 
76.5 
 
(χ2=.683, p=.409) 
 
Education 
Primary 
Secondary 
Higher 
 
14 
14 
7 
 
40 
40 
20 
 
5 
7 
5 
 
29.4 
41.2 
29.4 
(χ2=.794, p=.672) 
 
Professionally active (%)* 24 68.6 13 76.5 (χ2=.348, p=.555) 
 
Marital status** 
Married/stable couple 
Alone 
 
 
23 
12 
 
 
65.7 
34.3 
 
 
9 
8 
 
 
52.9 
47.1 
(χ2=.686, p=.408) 
      
 
Family dynamics (% normal)† 23 65.7 14 82.4 (χ2=1.543, p=.214) 
      
M: Mean; SD: Standard Deviation; FGD: functional gastrointestinal disorders (functional dyspepsia and irritable bowel syndrome); GMD: gastrointestinal motility 
disorders (chronic intestinal pseudo-obstruction, gastroparesis and inability). 
† Family dynamics: not normal denotes problems with their primary support group, as defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text 
revision Axis IV criteria (American Psychiatric Association, 2000) 
These categories were collapsed because of low n: 
*Any work activity or house keeping 
** Alone includes single, divorced and widow. 
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Table 2. Psychometric tests among different diagnosis (means±standard deviations). 
 
Psychometric test FGD GMD Significance FGD VS. 
GMD 
 
SF-36 (T scores) 
   
Physical  functioning 39.68±12.90 40.79 ± 14.40 (z=-.539, p=.590) 
Physical role 33.90±10.52 38.50 ± 11.93 (z=-2.186, p=.029) 
Pain 34.14±9.82 36.64 ± 9.49 (z=-1.309, p=.191) 
General health 36.82±10.09 35.50 ± 8.18 (z=-.659, p=.510) 
Vitality 37.64±10.44 38.36 ± 10.02 (z=-.192, p=.848) 
Social functioning 29.30±14.30 33.86 ± 13.10 (z=-1.772, p=.076) 
Emotional role 43.44±14.40 42.21 ± 15.23 (z=-.529, p=.597) 
Emotional well-being 42.22±11.93 43.57 ± 12.61 (z=-.036, p=.971) 
    
TAS 46.16±13.91 48.43 ± 17.15 (z=-.633, p=.527) 
 
HAD depression 
5.18±4.16 5.07 ± 4.58 (z=-.096, p=.924) 
 
HAD anxiety 
7.80±5.15 7.86 ± 5.82 (z=-.347, p=.729) 
 
SCL90-R (T scores) 
   
Somatization 62.90±8.44 61.58 ± 8.83 (z=-.527, p=.598) 
Obsessive-   compulsive 55.61±13.75 53.42 ± 15.57 (z=-.442, p=.659) 
Interpersonal  sensitivity 52.61±14.13 52.17 ± 13.87 (z=-.016, p=.987) 
Depression 59.76±14.76 58.83 ± 13.28 (z=-.278, p=.781) 
Anxiety 59.24±13.73 55.50 ± 15.35 (z=-.555, p=.579) 
Hostility 51.07±13.00 53.08 ± 13.56 (z=-.696, p=.486) 
Phobic anxiety 51.80±15.72 48.25 ± 16.02 (z=-.678, p=.498) 
Paranoid ideation 51.02±15.91 46.83 ± 13.71 (z=-.844, p=.399) 
Psychoticism 57.78±13.63 56.17 ± 15.43 (z=-.361, p=.718) 
 
NEO-FFI-R (T scores) 
   
Neuroticism 49.20±12.73 51.21 ± 13.47 (z=-.932, p=.352) 
Extraversion 47.71±9.83 47.86 ± 9.82 (z=-.323, p=.747) 
Openness to Experience 52.16±9.85 51.79 ± 8.71 (z=-.587, p=.557) 
Agreeableness 51.53±10.42 47.57 ± 13.10 (z=-.1.449, p=.147) 
Conscientiousness 54.00±8.92 52.79 ± 7.51 (z=-.743, p=.458) 
    
Karnofsky Performance 
Scale 
68.43±16.17 
 
64.12±20.15 (z=-0.832, p=0.405) 
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Figure 2. Scatter plots showing the correlation of clinical performance and subjective functionality of patients diagnosed with FGDs (up) and GMDs (down). 
 
 
